11/12
02:04 pm
atxs
Rating for ATXS
Low
Report
Rating for ATXS
11/12
12:58 pm
atxs
Astria Therapeutics (NASDAQ:ATXS) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.
Report
Astria Therapeutics (NASDAQ:ATXS) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.
11/12
11:28 am
atxs
Astria Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
Low
Report
Astria Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
10/16
08:08 am
atxs
Astria Therapeutics (NASDAQ:ATXS) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Astria Therapeutics (NASDAQ:ATXS) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
10/16
06:09 am
atxs
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/16
06:09 am
atxs
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/15
11:12 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS
10/15
11:12 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS
10/15
08:12 am
atxs
Astria Therapeutics (NASDAQ:ATXS) had its "market perform" rating reaffirmed by analysts at JMP Securities.
Low
Report
Astria Therapeutics (NASDAQ:ATXS) had its "market perform" rating reaffirmed by analysts at JMP Securities.
10/15
08:12 am
atxs
Astria Therapeutics (NASDAQ:ATXS) had its "market perform" rating reaffirmed by analysts at JMP Securities.
Low
Report
Astria Therapeutics (NASDAQ:ATXS) had its "market perform" rating reaffirmed by analysts at JMP Securities.
10/15
07:14 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS
10/15
07:14 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS
10/15
06:49 am
atxs
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
Low
Report
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
10/15
06:49 am
atxs
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
Low
Report
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
10/14
06:09 pm
atxs
Astria Therapeutics (NASDAQ:ATXS) was downgraded by analysts at Oppenheimer Holdings, Inc. from an "outperform" rating to a "market perform" rating.
Low
Report
Astria Therapeutics (NASDAQ:ATXS) was downgraded by analysts at Oppenheimer Holdings, Inc. from an "outperform" rating to a "market perform" rating.
10/14
04:35 pm
atxs
Astria Therapeutics downgraded to Perform from Outperform at Oppenheimer
Low
Report
Astria Therapeutics downgraded to Perform from Outperform at Oppenheimer
10/14
04:35 pm
atxs
Astria Therapeutics downgraded to Perform from Outperform at Oppenheimer
Low
Report
Astria Therapeutics downgraded to Perform from Outperform at Oppenheimer
10/14
02:13 pm
atxs
Rating for ATXS
Low
Report
Rating for ATXS
10/14
02:13 pm
atxs
Rating for ATXS
Low
Report
Rating for ATXS
10/14
01:05 pm
atxs
Astria Therapeutics downgraded to Hold from Buy at Jefferies
Low
Report
Astria Therapeutics downgraded to Hold from Buy at Jefferies
10/14
01:05 pm
atxs
Astria Therapeutics downgraded to Hold from Buy at Jefferies
Low
Report
Astria Therapeutics downgraded to Hold from Buy at Jefferies
10/1
12:03 pm
atxs
Astria Therapeutics (NASDAQ:ATXS) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Astria Therapeutics (NASDAQ:ATXS) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
10/1
12:03 pm
atxs
Astria Therapeutics (NASDAQ:ATXS) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Astria Therapeutics (NASDAQ:ATXS) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
9/17
10:21 am
atxs
Astria Therapeutics (NASDAQ:ATXS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $49.00 price target on the stock.
Medium
Report
Astria Therapeutics (NASDAQ:ATXS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $49.00 price target on the stock.
9/17
10:08 am
atxs
Rating for ATXS
Medium
Report
Rating for ATXS